Interventional Pulmonology Device Market Valued at $6.2B in 2024, Forecast to Exceed $10B by 2034 | Exactitude Consultancy

Interventional Pulmonology Device Market Report (2025–2034)

Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Market Overview

The global interventional pulmonology device market is projected to reach USD 6.2 billion in 2024 and is expected to exceed USD 10 billion by 2034, growing at a CAGR of approximately 6.3%. The market's expansion is primarily driven by:

The increasing prevalence of respiratory diseases
A growing geriatric population
Technological advancements in minimally invasive pulmonary procedures

Get a Sample PDF Brochure: https://exactitudeconsultancy.com/reports/65319/global-interventional-pulmonology-device-market#request-a-sample

Key Market Drivers (Detailed)

Rising Incidence of Respiratory Conditions
- Chronic Obstructive Pulmonary Disease (COPD) affects over 390 million people globally, with high prevalence in aging and smoking populations.
- Asthma cases are steadily rising, especially among children and in urban settings due to pollution.
- Lung cancer, often diagnosed late, requires advanced bronchoscopic biopsies—driving demand for diagnostic tools and navigation systems.
Aging Population
- As global life expectancy increases, so does the aging population (65+), who are more susceptible to respiratory diseases due to declining lung function.
- Geriatric patients require minimally invasive diagnostic and therapeutic options, such as robotic-assisted bronchoscopy and cryotherapy tools.
Innovation in Bronchoscopic Technologies
- Robotic-assisted bronchoscopy (e.g., Ion by Intuitive Surgical) allows for precise navigation into peripheral lung lesions.
- AI-powered imaging systems help detect lesions, assist in real-time decision-making, and reduce false negatives.
- Integration with 3D imaging and electromagnetic navigation improves procedural success rates.
Favorable Regulatory Trends
- Agencies like the FDA and EMA are expediting approvals for innovative minimally invasive devices.
- Coverage expansion by insurance companies for bronchial thermoplasty and navigational bronchoscopy is encouraging adoption.
- Increased government grants and public-private partnerships supporting lung cancer screening programs.

Market Challenges (Detailed)

High Procedure Costs
- Advanced equipment like robotic bronchoscopes and navigation systems cost hundreds of thousands of dollars.
- Limited adoption in developing nations and smaller hospitals due to high capital and maintenance costs.
Reimbursement Complexities
- Variability in insurance coverage across countries creates uncertainty for providers and patients.
- Some emerging procedures lack proper coding or are not included in standard coverage schemes, hampering widespread use.
Regulatory Hurdles
- Interventional pulmonology devices often face long and expensive clinical trial requirements, particularly for Class III devices.
- Cross-border regulatory harmonization remains a challenge for manufacturers expanding globally.
Supply Chain Disruptions
- The COVID-19 pandemic revealed fragility in global supply chains—impacting availability of scopes, catheters, and components.
- Ongoing geopolitical tensions, raw material shortages, and dependency on single-source suppliers remain key risks.

Growth Opportunities (Detailed)

AI & Smart Bronchoscopy Devices
- Companies are integrating machine learning algorithms to analyze real-time bronchoscopic video for better diagnosis.
- Smart catheters and scopes now include sensors that provide feedback on tissue interaction, force, and navigation.
Expanding Use Cases
- Beyond cancer, bronchoscopic tools are being used for:
  - Infectious disease diagnostics (e.g., TB, fungal infections).
  - Sleep apnea treatment via upper airway stimulation.
  - Interstitial lung disease biopsy with minimal trauma.
- Growing interest in therapeutic applications like localized drug delivery and stent placement.
Surging Healthcare Investments
- Asia-Pacific is projected to grow at CAGR ~8%, driven by:
  - Increasing government health budgets (India, China).
  - Rapid expansion of private hospitals.
  - Rising awareness about early lung disease detection.
Strategic Collaborations
- Partnerships between device manufacturers and tech firms (e.g., AI developers, imaging companies).
- Licensing deals and co-development agreements enhancing R&D capabilities.
- Collaborations with academic institutions accelerating innovation in diagnostics and surgical training tools.

Market Segmentation

By Product Type

The interventional pulmonology devices market is segmented into bronchoscopes, biopsy forceps, endobronchial valves, bronchial dilators, stents, and other devices. Bronchoscopes hold the largest market share, estimated at around 30%, driven by the growing adoption of robotic-assisted systems that allow for enhanced precision, especially in lung cancer diagnostics and treatment. Biopsy forceps account for about 10% of the market, supported by advances that increase tissue sampling accuracy for early cancer detection. Endobronchial valves, making up 15% of the market, are vital for lung volume reduction procedures in COPD patients. Bronchial dilators (20% share) are in high demand due to their role in airway stenosis management. Stents contribute approximately 12% of the market, with innovations such as self-expanding and drug-eluting designs driving their growth. The remaining 13% includes various specialized tools like navigational aids, cryoprobes, and catheters, used in advanced diagnostic and therapeutic interventions.

Product Type	Estimated Share (%)	Key Trends
Bronchoscopes	30%	Increasing adoption of robotic systems
Biopsy Forceps	10%	Enhanced precision in lung cancer diagnostics
Endobronchial Valves	15%	Key in lung volume reduction procedures
Bronchial Dilators	20%	Demand driven by airway management needs
Stents	12%	Innovations in self-expanding and drug-eluting designs
Other Devices	13%	Includes navigational aids and catheters

By Application

In terms of application, oncology represents the largest segment, accounting for around 45% of the market. This dominance is attributed to the rising global burden of lung cancer and the increasing use of bronchoscopy for early detection, biopsy, and treatment. Respiratory diseases, including COPD and asthma, follow with a 30% share, fueled by aging populations and increasing environmental risk factors. Infectious diseases, such as tuberculosis and pneumonia, make up 15% of the market, with flexible bronchoscopy playing a central role in accurate diagnosis and treatment. Sleep apnea, with a 10% share, is an emerging application area benefiting from growing awareness, diagnostics, and minimally invasive interventional therapies such as airway stimulation and dilation.

Application	Share (%)	Notes
Oncology	45%	Lung cancer diagnostics and treatment
Respiratory Diseases	30%	Includes COPD, asthma
Infectious Diseases	15%	TB, pneumonia diagnostics
Sleep Apnea	10%	Growing with increasing diagnosis rates

By End User

Hospitals dominate the end user segment, accounting for approximately 60% of all procedures, owing to their comprehensive infrastructure, skilled personnel, and capacity for high procedure volumes. Ambulatory Surgical Centers (ASCs) follow with a 20% share, driven by the rising demand for outpatient bronchoscopy and cost-effective care settings. Specialty clinics, comprising around 10%, cater to respiratory and oncology-specific needs with dedicated technologies and expertise. Research institutions, although a smaller segment at 5%, play a crucial role in clinical trials, device development, and the early adoption of cutting-edge bronchoscopy technologies.

End User	Share (%)
Hospitals	60%
Ambulatory Surgical Centers (ASCs)	20%
Specialty Clinics	10%
Research Institutions	5%

By Procedure Type

Based on procedure type, diagnostic procedures lead the market with a 40% share, supported by the increasing need for accurate detection of lung cancer, infections, and airway obstructions through advanced biopsy and imaging-guided tools. Therapeutic procedures hold a 35% share and include treatments such as stenting, cryotherapy, and laser ablation to manage airway tumors or strictures. Surgical procedures account for 25% of the market and are expanding in scope with the introduction of robotic-assisted bronchoscopy, allowing safer and more precise access to peripheral lung lesions.

Procedure Type	Share (%)
Diagnostic	40%
Therapeutic	35%
Surgical	25%

By Technology

Technologically, flexible bronchoscopy remains the most widely used approach, preferred for its versatility in both diagnostic and therapeutic settings. Rigid bronchoscopy, although more invasive, is crucial in complex therapeutic interventions such as tumor debulking and managing significant airway obstructions. Robotic-assisted bronchoscopy is the fastest-growing technological segment, offering unparalleled precision in navigating to small or hard-to-reach pulmonary nodules. This innovation is particularly valuable in early-stage cancer diagnosis and is gaining traction among leading hospitals and specialty centers.

Flexible Bronchoscopy
Rigid Bronchoscopy
Robotic-Assisted Bronchoscopy

By Distribution Channel

The market is distributed through two main channels: direct sales and distributors. Direct sales dominate in large hospitals and integrated health systems, where bulk procurement and customized service agreements are common. Distributors play a critical role in reaching smaller clinics, ASCs, and healthcare providers in emerging markets, helping to bridge supply gaps and expand product accessibility across regions with limited direct manufacturer presence.

Direct Sales
Distributors

By Region

Regionally, North America holds the largest share of the interventional pulmonology devices market—approximately 45%—fueled by a well-developed healthcare infrastructure, high prevalence of respiratory conditions, and early adoption of advanced technologies such as robotic bronchoscopy. Europe follows with significant market presence due to strong healthcare systems and a growing preference for minimally invasive pulmonary interventions. The Asia-Pacific region is the fastest-growing, with an estimated CAGR of 8%, driven by rapid urbanization, rising healthcare investments, and increasing incidence of respiratory diseases. Latin America is witnessing steady growth as awareness programs and public health initiatives improve access to care. Meanwhile, the Middle East & Africa region is emerging as a promising market, with expanding healthcare services and a rising burden of respiratory infections contributing to increased demand for interventional pulmonology solutions.

Region	Key Highlights
North America	45% of market share, driven by advanced healthcare infrastructure
Europe	Strong focus on minimally invasive solutions
Asia-Pacific	Fastest growth due to healthcare reforms and investment
Latin America	Gradual adoption, driven by public health campaigns
Middle East & Africa	Emerging opportunities amid rising respiratory disease burden

Browse full Report - https://exactitudeconsultancy.com/reports/65319/global-interventional-pulmonology-device-market

Key Players

· Medtronic plc

· Boston Scientific Corporation

· Johnson & Johnson (Ethicon, Inc.)

· Olympus Corporation

· Siemens Healthineers AG

· AngioDynamics Inc.

· Teleflex Incorporated

· Cook Medical LLC

· ConMed Corporation

· Merit Medical Systems, Inc.

· C.R. Bard, Inc. (Becton, Dickinson and Company)

· Neuwave Medical (Johnson & Johnson subsidiary)

· Hologic, Inc.

· Asahi Intecc Co., Ltd.

· Lumenis Ltd.

· Smiths Medical (ICU Medical)

· FUJIFILM Holdings Corporation

· KARL STORZ SE & Co. KG

· Broncus Medical, Inc.

· Veran Medical Technologies

Recent Developments:

· Medtronic: In December 2023, Medtronic announced a collaboration with Cosmo Pharmaceuticals to integrate artificial intelligence into endoscopic procedures. This partnership aims to enhance diagnostic accuracy and patient outcomes in interventional pulmonology.

· Boston Scientific Corporation: In November 2023, Boston Scientific completed the acquisition of Relievant Medsystems, Inc., expanding its portfolio in interventional pain management solutions. This acquisition adds the Intracept® system, a minimally invasive treatment for vertebrogenic pain, to Boston Scientific’s offerings.

· Johnson & Johnson (Ethicon): In June 2023, Ethicon entered a strategic partnership with a technology firm specializing in AI-driven pulmonary diagnostics. This collaboration focuses on developing advanced solutions to improve the accuracy and efficiency of lung disease diagnosis.

· Olympus Corporation: In September 2023, Olympus launched enhancements to its endoscopic imaging systems, incorporating augmented reality features. These advancements aim to improve visualization and precision during interventional pulmonology procedures.

· Teleflex Incorporated: In October 2023, Teleflex received regulatory approval for its innovative bronchial intervention device designed for patients with severe asthma. This approval allows Teleflex to address a significant unmet need in asthma management.

This report is also available in the following languages : Japanese (インターベンショナル肺疾患デバイス市場), Korean (중재적 폐의학 기기 시장), Chinese (介入性肺病学设备市场), French (Marché des dispositifs de pneumologie interventionnelle), German (Markt für interventionelle Pulmonologiegeräte), and Italian (Mercato dei dispositivi di pneumologia interventistica), etc.

Get a Sample PDF Brochure: https://exactitudeconsultancy.com/reports/65319/global-interventional-pulmonology-device-market#request-a-sample

More Research Finding –

Interventional Lung Solutions Market
The interventional lung solutions market is projected to reach a value of approximately $3.2 billion in 2024, driven by rising lung disease prevalence and advancements in medical technologies. Forecasts indicate a substantial growth trajectory, with the market anticipated to expand at a Compound Annual Growth Rate (CAGR) of 7.5% from 2025 to 2034, potentially reaching around $6 billion by 2034.
https://exactitudeconsultancy.com/reports/65564/interventional-lung-solutions-market

U.S. Disposable Endoscope Market
The U.S. disposable endoscope market is projected to reach approximately $1.2 billion in 2024, driven by increasing demand for minimally invasive procedures and heightened awareness of infection control. The market is forecasted to expand significantly, with an expected value of $3.5 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 11.4% during the 2025–2034 period.
https://exactitudeconsultancy.com/reports/50475/u-s-disposable-endoscope-market

Bronchoscopy Market
The global bronchoscopy market is valued at approximately $3.5 billion in 2024, with projections indicating substantial growth to around $5.9 billion by 2034. This reflects a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/50257/bronchoscopy-market

Bronchoscopes Market
The global bronchoscopes market size is to be valued at USD 42.29 billion by 2029 and is expected to grow at a compound annual growth rate (CAGR) of 8.3% during the forecast period.
https://exactitudeconsultancy.com/reports/12970/bronchoscopes-market

Colonoscopy Devices Market
The global colonoscopy devices market is valued at approximately $2.5 billion in 2024 and is projected to reach around $4 billion by 2034, demonstrating a robust Compound Annual Growth Rate (CAGR) of 4.7% over the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/49954/colonoscopy-devices-market

Fluorescence Endoscopy System Market
The global fluorescence endoscopy system market is valued at approximately $1.2 billion in 2024 and is projected to reach $2.5 billion by 2034, reflecting a compound annual growth rate (CAGR) of 7.6% during the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/65632/fluorescence-endoscopy-system-market

Disposable Coaxial Biopsy Needle Market
The global market for disposable coaxial biopsy needles is valued at approximately $600 million in 2024, driven by an increasing demand for minimally invasive diagnostic procedures. It is projected to reach around $900 million by 2034, reflecting significant growth opportunities. The estimated Compound Annual Growth Rate (CAGR) during the forecast period of 2025 to 2034 is approximately 4.3%, influenced by advancements in imaging technologies and rising awareness of early cancer detection.
https://exactitudeconsultancy.com/reports/64857/disposable-coaxial-biopsy-needle-market

Endoscope Optics Objective Market
The global endoscope optics market is valued at approximately $5.1 billion in 2024, with projections indicating a substantial increase to around $8.2 billion by 2034. This represents a Compound Annual Growth Rate (CAGR) of approximately 5.0% for the forecast period (2025–2034).
https://exactitudeconsultancy.com/reports/63824/global-endoscope-optics-objective-market

Single Use Video Endoscope Market
The global single-use video endoscope market is poised for significant growth, valued at approximately $2.1 billion in 2024. Projections suggest an increase to around $4.8 billion by 2034, driven by rising demand for minimally invasive procedures and advancements in endoscopic technology. The Compound Annual Growth Rate (CAGR) for the period from 2025 to 2034 is estimated at 8.7%, indicating robust market expansion.
https://exactitudeconsultancy.com/reports/62871/global-single-use-video-endoscope-market

Fiber Optic Endoscope Market
The global fiber optic endoscope market is valued at approximately $2.6 billion in 2024 and is projected to reach around $4.5 billion by 2034, reflecting significant growth opportunities. This translates to a Compound Annual Growth Rate (CAGR) of about 6.2% during the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/62691/global-fiber-optic-endoscope-market

Medical Endoscopy Equipment Market
The global medical endoscopy equipment market is valued at approximately $46 billion in 2024, with projections indicating growth to around $66 billion by 2034. This translates to a robust compound annual growth rate (CAGR) of 3.8% during the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/60170/global-medical-endoscopy-equipment-market

Ocean Wet Suction Water Seal Chest Drain Market
The global market for ocean wet suction water seal chest drains is valued at approximately $450 million. This market is expected to grow significantly, projecting a value of around $750 million by 2034. The calculated Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 stands at about 5.4%.
https://exactitudeconsultancy.com/reports/59614/global-ocean-wet-suction-water-seal-chest-drain-market

Semi-automatic Biopsy Needle Market
The global semi-automatic biopsy needle market is poised to reach approximately $650 million in 2024, driven by increasing diagnostic procedures and advancements in minimally invasive techniques. The market is projected to grow significantly, with an estimated market value of around $1.1 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of about 5.2% during the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/59339/global-semi-automatic-biopsy-needle-market

Endoscope Camera System Market
The global endoscope camera system market is valued at approximately $4.1 billion in 2024, with expectations to reach around $6.9 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of about 5.5% during the forecast period (2025-2034).
https://exactitudeconsultancy.com/reports/58603/global-endoscope-camera-system-market

Interactive Stethoscope Market
The global interactive stethoscope market is valued at approximately USD 1.2 billion in 2024, with a projected compound annual growth rate (CAGR) of 12% from 2025 to 2034, anticipating a market value of about USD 3.7 billion by 2034.
https://exactitudeconsultancy.com/reports/54925/global-interactive-stethoscope-market

Endoscopic Retrieval Device Market
The global endoscopic retrieval device market is estimated to reach a value of approximately $1.6 billion in 2024, driven by advancements in minimally invasive surgical techniques and the rising prevalence of gastrointestinal disorders. The market is expected to witness substantial growth, projected to reach around $2.8 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of approximately 6.3% during the forecast period from 2025 to 2034.
https://exactitudeconsultancy.com/reports/54412/global-endoscopic-retrieval-device-market

Non-vascular Lumen Guidewire Market
The global non-vascular lumen guidewire market is valued at approximately $1.2 billion in 2024, with projections for substantial growth over the forecast period (2025–2034), anticipating a market value of $2.4 billion by 2034. This trajectory represents a Compound Annual Growth Rate (CAGR) of around 7.2%.
https://exactitudeconsultancy.com/reports/53829/global-non-vascular-lumen-guidewire-market

Endoscopic Ultrasound Guided Needles Market
The global market for endoscopic ultrasound (EUS) guided needles is poised for significant growth, with an estimated value of approximately $330 million in 2024. Projections suggest that the market will reach about $600 million by 2034, reflecting a robust expansion during the forecast period. This growth translates to a Compound Annual Growth Rate (CAGR) of around 6.5% from 2025 to 2034.
https://exactitudeconsultancy.com/reports/53221/global-endoscopic-ultrasound-guided-needles-market

Wireless Endoscopes Market
The global wireless endoscopy market is valued at approximately $1.2 billion in 2024, with projections indicating a significant rise to around $2.8 billion by 2034. This growth reflects a Compound Annual Growth Rate (CAGR) of approximately 9% during the forecast period (2025–2034).
https://exactitudeconsultancy.com/reports/53129/global-wireless-endoscopes-market

Irfan Tamboli (Head of Sales)
Phone: + 1704 266 3234
Email: sales@exactitudeconsultancy.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.